Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Golden State Equity Partners »

Alnylam Pharmaceuticals shares owned by Golden State Equity Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Golden State Equity Partners from 13F filings

Historical chart of Golden State Equity Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Golden State Equity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Golden State Equity Partners

Quarter filed	Position value	Share count	Share price at filing
2026-06-30	$30k	100	301.03
2026-03-31	$64k	194	330.50
2024-09-30	$6.3k	23	275.00

More positions owned by Golden State Equity Partners

Invesco Qqq Tr Uit Exchange Traded (QQQ)

Ishares Core S&p 500 Uit Exchange Traded (IVV)

Ishares 20 Year Uit Exchange Traded (TLTW)

Ishares 0-3 Month Uit Exchange Traded (SGOV)

Janus Henderson Aaa Clo Uit Exchange Traded (JAAA)

Ishares Russell Mid-cap Uit Exchange Traded (IWP)

Vanguard Short-term Uit Exchange Traded (VGSH)

Vanguard Small-cap Uit Exchange Traded (VBK)

Vanguard Ftse All-world Uit Exchange Traded (VEU)

Invesco Senior Loan Etf Uit Exchange Traded (BKLN)

Ishares Gold Trust Uit Exchange Traded (IAU)

Ishares Floating Rate Uit Exchange Traded (FLOT)

Vanguard Uit Exchange Traded (BIV)

Ishares Broad Usd High Uit Exchange Traded (USHY)

State Street Blackstone Uit Exchange Traded (SRLN)

View all positions for Golden State Equity Partners

Top funds holding Alnylam Pharmaceuticals

Capital World Investors

Capital Research Global Investors

Vanguard Portfolio Management

Vanguard Capital Management

State Street Corporation

Jpmorgan Chase & Co

Geode Capital Management

Baillie Gifford & Co

Norges Bank Investment Management

Wellington Management Company

Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z